Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma

Bringing migration research under one roof.

Funded by Led by

This project was made possible thanks to funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement Ares(2017) 5627812-77012.